About AirSculpt Technologies, Inc. 
AirSculpt Technologies, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 17 Schemes (3.46%)
Foreign Institutions
Held by 19 Foreign Institutions (1.23%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
44 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
Pharmaceuticals & Biotechnology
USD 184 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.72
-9.37%
2.24






